TrialDiabetes care2018

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.

Silvio E Inzucchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.